• Sensus Healthcare posted a net loss of $2.6 million, or $0.16 per share, for the three months ended March 31, 2026, roughly in line with the year-ago loss.
• Revenue dropped to $3.4 million from $8.3 million a year earlier, reflecting no sales to its historically largest customer and fewer units shipped.
• Gross margin fell to 29.2% from 52.2% a year earlier, due to product mix and a higher share of Fair Deal Agreement and rental placements that defer revenue recognition.
• Shipped 14 SRT systems versus 30 a year earlier; Fair Deal Agreement treatment volumes rose 8% with 18 active sites and nine pending activation.
• Management highlighted dedicated CPT codes for SRT and IG-SRT effective Jan. 1, 2026, citing stronger customer inquiries and pipeline activity, while ending quarter with $18.3 million in cash and no debt.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605071605BIZWIRE_USPR_____20260507_BW781798) on May 07, 2026, and is solely responsible for the information contained therein.